A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET

Autor: Andrew W. Duncan, Yong-Kook Kwon, Arman Zarnegar, Xinping Tan, Marie C. DeFrances, Evan R. Delgado, Jihong Ma, Reza Zarnegar

Publikováno v: Cellular and Molecular Gastroenterology and Hepatology
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 2, Pp 565-582 (2022)

Background & Aims Nonalcoholic fatty liver disease is a frequent cause of hepatic dysfunction and is now a global epidemic. This ailment can progress to an advanced form called nonalcoholic steatohepatitis (NASH) and end-stage liver disease. Currentl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30958d41e6dcdb7086f377f001ad86cf
https://pubmed.ncbi.nlm.nih.gov/34756982